These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9673781)

  • 1. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler.
    Soria I; Harrison LI; Machacek JH; Cline AC; Stampone PA
    Biopharm Drug Dispos; 1998 Jul; 19(5):297-302. PubMed ID: 9673781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local versus total systemic bioavailability of beclomethasone dipropionate CFC and HFA metered dose inhaler formulations.
    Harrison LI
    J Aerosol Med; 2002; 15(4):401-6. PubMed ID: 12581506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times.
    Leach CL; Colice GL
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):355-61. PubMed ID: 20575669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL; Davidson PJ; Boudreau RJ
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J; Qualtrough J; Perrin VL
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
    Rony F; Cortellini M; Guasconi A; Mathews KS; Piccinno A; Poli G; Vanhoutte F; Klein J
    Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH; Melchior A; Dunbar SA; Tantry SK; Dorinsky PM
    Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
    Ayres JG; Simmons JL; Stampone P
    Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate.
    Lipworth BJ; Jackson CM
    Br J Clin Pharmacol; 1999 Dec; 48(6):866-8. PubMed ID: 10594492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.
    Harrison LI; Soria I; Cline AC; Ekholm BP
    J Pharm Pharmacol; 1999 Nov; 51(11):1235-40. PubMed ID: 10632080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.